Watch for Zelnorm's Return for Irritable Bowel Syndrome With Constipation

Tegaserod (Zelnorm) will be back on the market to treat irritable bowel syndrome with constipation (IBS-C) in women.

It was first approved in 2002...then taken off the market in 2007 due to reports of MI, stroke, and unstable angina.

Since then, it's been available on a case-by-case basis from various manufacturers.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals